MLYS logo

Mineralys Therapeutics (MLYS) Selling, General & Administrative Expenses

Annual SGA

$23.82 M
+$9.53 M+66.63%

December 31, 2024


Summary


Performance

MLYS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYSexpensesmetrics:

Quarterly SGA

$7.20 M
+$1.08 M+17.60%

December 31, 2024


Summary


Performance

MLYS Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYSexpensesmetrics:

TTM SGA

-$909.54 M
-$177.81 M-24.30%

December 31, 2024


Summary


Performance

MLYS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYSexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

MLYS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+66.6%+78.8%-6462.2%
3 y3 years+885.6%+78.8%-6462.2%
5 y5 years+4377.8%+78.8%-6462.2%

MLYS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+885.6%at high+810.0%-1262.6%at low
5 y5-yearat high+4377.8%at high+1441.3%-3852.6%at low
alltimeall timeat high+4377.8%at high+1441.3%-3852.6%at low

Mineralys Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$23.82 M(+66.6%)
$7.20 M(+17.6%)
$23.82 M(+15.4%)
Sep 2024
-
$6.12 M(+3.8%)
$20.65 M(+12.8%)
Jun 2024
-
$5.89 M(+27.9%)
$18.30 M(+12.6%)
Mar 2024
-
$4.61 M(+14.5%)
$16.26 M(+13.7%)
Dec 2023
$14.30 M
$4.03 M(+6.7%)
$14.30 M(+14.7%)
Sep 2023
-
$3.77 M(-2.0%)
$12.46 M(+24.0%)
Jun 2023
-
$3.85 M(+45.6%)
$10.05 M(+41.9%)
DateAnnualQuarterlyTTM
Mar 2023
-
$2.65 M(+20.8%)
$7.08 M(+35.5%)
Dec 2022
$5.23 M(+116.3%)
$2.19 M(+60.6%)
$5.23 M(+49.1%)
Sep 2022
-
$1.36 M(+54.3%)
$3.51 M(+63.7%)
Jun 2022
-
$884.00 K(+11.8%)
$2.14 M(+70.3%)
Mar 2022
-
$791.00 K(+69.4%)
$1.26 M(+169.4%)
Dec 2021
$2.42 M(+354.3%)
-
-
Dec 2021
-
$467.00 K
$467.00 K
Dec 2020
$532.00 K
-
-

FAQ

  • What is Mineralys Therapeutics annual SGA?
  • What is the all time high annual SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual SGA year-on-year change?
  • What is Mineralys Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly SGA year-on-year change?
  • What is Mineralys Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics TTM SGA year-on-year change?

What is Mineralys Therapeutics annual SGA?

The current annual SGA of MLYS is $23.82 M

What is the all time high annual SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual SGA is $23.82 M

What is Mineralys Therapeutics annual SGA year-on-year change?

Over the past year, MLYS annual SGA has changed by +$9.53 M (+66.63%)

What is Mineralys Therapeutics quarterly SGA?

The current quarterly SGA of MLYS is $7.20 M

What is the all time high quarterly SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly SGA is $7.20 M

What is Mineralys Therapeutics quarterly SGA year-on-year change?

Over the past year, MLYS quarterly SGA has changed by +$3.17 M (+78.79%)

What is Mineralys Therapeutics TTM SGA?

The current TTM SGA of MLYS is -$909.54 M

What is the all time high TTM SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high TTM SGA is -$23.01 M

What is Mineralys Therapeutics TTM SGA year-on-year change?

Over the past year, MLYS TTM SGA has changed by -$923.83 M (-6462.17%)